PL3515409T3 - Kompleks i kompozycje do leczenia chorób okulistycznych i dermatologicznych - Google Patents
Kompleks i kompozycje do leczenia chorób okulistycznych i dermatologicznychInfo
- Publication number
- PL3515409T3 PL3515409T3 PL17786829T PL17786829T PL3515409T3 PL 3515409 T3 PL3515409 T3 PL 3515409T3 PL 17786829 T PL17786829 T PL 17786829T PL 17786829 T PL17786829 T PL 17786829T PL 3515409 T3 PL3515409 T3 PL 3515409T3
- Authority
- PL
- Poland
- Prior art keywords
- ophthalmic
- compositions
- complex
- treatment
- dermatological diseases
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102016000096125A IT201600096125A1 (it) | 2016-09-26 | 2016-09-26 | Complesso e composizioni per il trattamento di affezioni oculari e cutanee |
| PCT/EP2017/074337 WO2018055194A1 (en) | 2016-09-26 | 2017-09-26 | Complex and compositions for the treatment of ophthalmic and dermatological diseases |
| EP17786829.6A EP3515409B1 (en) | 2016-09-26 | 2017-09-26 | Complex and compositions for the treatment of ophthalmic and dermatological diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3515409T3 true PL3515409T3 (pl) | 2021-05-31 |
Family
ID=57960613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17786829T PL3515409T3 (pl) | 2016-09-26 | 2017-09-26 | Kompleks i kompozycje do leczenia chorób okulistycznych i dermatologicznych |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3515409B1 (pl) |
| DK (1) | DK3515409T3 (pl) |
| ES (1) | ES2841940T3 (pl) |
| IT (1) | IT201600096125A1 (pl) |
| MA (1) | MA46415B1 (pl) |
| PL (1) | PL3515409T3 (pl) |
| SM (1) | SMT202100070T1 (pl) |
| WO (1) | WO2018055194A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL279446B2 (en) * | 2018-06-15 | 2025-05-01 | Croma Pharma Gmbh | A hydrogel-based preparation containing a cross-linked polymer |
| IT201800008192A1 (it) * | 2018-08-27 | 2020-02-27 | Ira St Ricerche Applicate Spa | Microsfere di acido ialuronico reticolato con urea e contenenti almeno un agente attivo o farmaco |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5679655A (en) * | 1993-08-04 | 1997-10-21 | Patent Biopharmaceutics, Inc. | Method of treating lesions resulting from genital herpes with hyaluronic acid-urea pharmaceutical compositions |
| ITMI20030195A1 (it) * | 2003-02-06 | 2004-08-07 | Bsd Bioscience Dev Snc Di O Mini C E Zucc | Formulazioni topiche contenenti principi attivi naturali adatte alla prevenzione e cura dei processi infiammatori delle mucose |
| US20090036554A1 (en) * | 2007-08-01 | 2009-02-05 | Burke Susan E | Ophthalmic compositions comprising a terpene compound |
| US8128968B2 (en) | 2007-08-29 | 2012-03-06 | Tissuetech, Inc. | Compositions and methods for treating Demodex infestations |
| ITMI20131193A1 (it) * | 2013-07-16 | 2015-01-17 | Ira Srl | Acido ialuronico reticolato, processo per la sua preparazione ed applicazioni in ambito estetico |
-
2016
- 2016-09-26 IT IT102016000096125A patent/IT201600096125A1/it unknown
-
2017
- 2017-09-26 SM SM20210070T patent/SMT202100070T1/it unknown
- 2017-09-26 WO PCT/EP2017/074337 patent/WO2018055194A1/en not_active Ceased
- 2017-09-26 MA MA46415A patent/MA46415B1/fr unknown
- 2017-09-26 PL PL17786829T patent/PL3515409T3/pl unknown
- 2017-09-26 ES ES17786829T patent/ES2841940T3/es active Active
- 2017-09-26 EP EP17786829.6A patent/EP3515409B1/en active Active
- 2017-09-26 DK DK17786829.6T patent/DK3515409T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3515409A1 (en) | 2019-07-31 |
| IT201600096125A1 (it) | 2018-03-26 |
| DK3515409T3 (da) | 2021-01-11 |
| MA46415A (fr) | 2019-07-31 |
| MA46415B1 (fr) | 2021-02-26 |
| EP3515409B1 (en) | 2020-10-28 |
| WO2018055194A1 (en) | 2018-03-29 |
| ES2841940T3 (es) | 2021-07-12 |
| SMT202100070T1 (it) | 2021-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3600309T3 (pl) | Skojarzenia terapeutyczne do leczenia chorób wątroby | |
| IL268850A (en) | Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases | |
| IL262608A (en) | Combination treatment of ocular inflammatory disorders and diseases | |
| EP3390634A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISEASES | |
| SI3377637T1 (sl) | Sestavki za uporabo pri postopkih za zdravljenje ran, motenj in bolezni kože | |
| GB201517215D0 (en) | Use of cannabinoids in the treatment of inflammatory skin diseases | |
| HUE053309T2 (hu) | Új sók és gyógyászati készítmények gyulladásos betegségek kezelésére | |
| EP3177732A4 (en) | Compositions and methods for the treatment of ophthalmic diseases and conditions | |
| HUE061761T2 (hu) | Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében | |
| IL273705B (en) | Benzothiazol compounds and methods using the same for treating neurodegenerative disorders | |
| IL269158A (en) | Compositions and methods for treating inflammatory diseases | |
| PT3481846T (pt) | 24-hidroxiesteroides 11-substituídos para utilização no tratamento de afeções relacionadas com nmda | |
| PL3381451T3 (pl) | Kompozycja farmaceutyczna stosowana do redukcji zlokalizowanej tkanki tłuszczowej i zastosowanie kompozycji farmaceutycznej | |
| IL264070A (en) | Methods and compositions for treatment of disorders and diseases involving rdh12 | |
| HUE051296T2 (hu) | Benzoxazinon-származékok bõrbetegségek kezelésére | |
| IL272601A (en) | Pharmaceutical compositions for the treatment of ophthalmic conditions | |
| HUE060496T2 (hu) | Terápiás vegyületek és készítmények szociális zavarok és szerhasználati zavarok kezelésére | |
| EP3268007A4 (en) | Compositions and therapeutic methods for the treatment of complement-associated diseases | |
| IL269083A (en) | Methods for preventing and treating heart disease | |
| IL268720A (en) | Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases | |
| IL269363A (en) | Methods for measuring therapeutic effects of retinal disease therapies | |
| HUE059387T2 (hu) | Parkinson-kór kezelése | |
| IL270900A (en) | Treatment of cutaneous disorders | |
| IL262508A (en) | Methods and compositions for the treatment of degenerate bone | |
| IL264407A (en) | Novel application of gzd824 and pharmaceutically acceptable salts thereof in treating diseases |